TrialEmerging infectious diseases2022
High-Dose Convalescent Plasma for Treatment of Severe COVID-19.
Gil C De Santis et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this paperpooled ittrialcites it
TrialEmerging infectious diseases2022
Gil C De Santis et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.